产后出血预防和治疗的核心结局集:一项国际德尔菲共识研究
该研究通过两轮德尔菲调查和面对面会议制定产后出血预防和治疗的核心结局集(COS)。预防研究选定9个核心结局,治疗研究选定12个核心结局,并制定报告建议,以标准化产后出血试验的结局报告。
要点
- 预防产后出血的COS包含9个核心结局。
- 治疗产后出血的COS包含12个核心结局。
- 该COS有助于标准化产后出血试验的结局报告。
核心结论
- 这些COS将有助于标准化产后出血试验的结局报告。
研究设计与样本
- 采用两轮德尔菲调查和面对面会议,参与者为医疗专业人员和女性代表,结局来自产后出血研究的系统评价和利益相关者咨询。
- 预防部分两轮德尔菲完成者为152/205(74%),治疗部分为143/197(73%)。
- 德尔菲中每个结局按1(不重要)至9(至关重要)的Likert量表评分,面对面会议共识定义为≥70%的参与者评为至关重要(7-9分)。
主要发现
- 预防产后出血选定9个核心结局:失血量、休克、孕产妇死亡、额外使用宫缩剂、输血、转诊至更高级别照护、女性幸福感、对干预的可接受性和满意度、母乳喂养及不良效应。
- 治疗产后出血选定12个核心结局:失血量、休克、凝血病、子宫切除术、器官功能障碍、孕产妇死亡、输血、额外使用止血干预、转诊至更高级别照护、女性幸福感、对干预的可接受性和满意度、母乳喂养及不良效应。
- 在可能的情况下,针对这些结局的报告方式制定了建议。
关键数值与推荐
- 预防产后出血的核心结局集包含9个核心结局。
- 治疗产后出血的核心结局集包含12个核心结局。
- 面对面会议共识定义为≥70%的参与者将结局评为至关重要(7-9分)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop core outcome sets (COS) for studies evaluating interventions for (1) prevention and (2) treatment of postpartum haemorrhage (PPH), and recommendations on how to report the COS. DESIGN: A two-round Delphi survey and face-to-face meeting. POPULATION: Healthcare professionals and women's representatives. METHODS: Outcomes were identified from systematic reviews of PPH studies and stakeholder consultation. Participants scored each outcome in the Delphi on a Likert scale between 1 (not important) and 9 (critically important). Results were discussed at the face-to-face meeting to agree the final COS. Consensus at the meeting was defined as ≥ 70% of participants scoring the outcome as critically important (7-9). Lectures, discussion and voting were used to agree how to report COS outcomes. MAIN OUTCOME MEASURES: Outcomes from systematic reviews and consultations. RESULTS: Both Delphi rounds were completed by 152/205 (74%) participants for prevention and 143/197 (73%) for treatment. For prevention of PPH, nine core outcomes were selected: blood loss, shock, maternal death, use of additional uterotonics, blood transfusion, transfer for higher level of care, women's sense of wellbeing, acceptability and satisfaction with the intervention, breastfeeding, and adverse effects. For treatment of PPH, 12 core outcomes were selected: blood loss, shock, coagulopathy, hysterectomy, organ dysfunction, maternal death, blood transfusion, use of additional haemostatic intervention, transfer for higher level of care, women's sense of wellbeing, acceptability and satisfaction with the intervention, breastfeeding, and adverse effects. Recommendations were developed on how to report these outcomes where possible. CONCLUSIONS: These COS will help standardise outcome reporting in PPH trials. TWEETABLE ABSTRACT: Core outcome sets for PPH: nine core outcomes for PPH prevention and 12 core outcomes for PPH treatment.
引用
- Meher S, Cuthbert A, Kirkham JJ, et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG. 2018. PMID: 29920912. doi:10.1111/1471-0528.15335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。